Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Infection Control
- Vancomycin-resistant enterococci.Lancet. 1988; 1: 57-58
- Vancomycin-resistant Enterococcus faecium in a liver transplant patient.Aust NZ J Med. 1995; 25: 560
- Emergence and epidemiology of vancomycin-resistant enterococci in Australia.Commun Dis Intell. 1998; 22: 249-252
- CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.Am J Infect Control. 2008; 36: 309-332
- Natural history of colonization with vancomycin-resistant Enterococcus faecium.Infect Control Hosp Epidemiol. 1995; 16: 680-685
- Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.Am Surg. 2003; 69: 514-519
- Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.Clin Infect Dis. 2005; 41: 327-333
- Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial Resistance.Commun Dis Intell. 2007; 31: 392-397
- Safety and efficacy of the antiseptic chlorhexidine gluconate.Surg Gynecol Obstet. 1976; 143: 789-792
- Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery.Am J Infect Control. 2007; 35: 89-96
- The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.Crit Care Med. 2009; 37: 1858-1865
- Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci.Arch Intern Med. 2006; 166: 306-312
- Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.J Clin Microbiol. 1995; 33: 1434
- Daily chlorohexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections.Am J Infect Control. 2010; 38: 817-821
- Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients.Arch Surg. 2010; 145: 240-246
- Risk of acquiring antibiotic-resistant bacteria from prior room occupants.Arch Intern Med. 2006; 166: 1945-1951
- Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants.Arch Intern Med. 2011; 171: 491-494
- A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control.Infect Control Hosp Epidemiol. 2001; 22: 140-147
- Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.Arch Intern Med. 2003; 163: 1905-1912
- Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital.Infect Control Hosp Epidemiol. 2008; 29: 398-403
- Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients.Infect Control Hosp Epidemiol. 2011; 32: 238-243
- Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients.Arch Intern Med. 2007; 167: 2073-2079
PB and SK contributed equally to this article.
Conflict of interest: An unrestricted travel grant was received from the supplier of the chlorhexidine-impregnated washcloths (AMCLA P/L) to support presentation of interim results at the Hospital Infection Society annual meeting. The supplier did not have any role in the study design or analysis, nor the decision for publication.